Browse by Audience
MEMBER

Update Your Profile
Member Spotlights
Refer a Member: IASP Champions
Join a Special Interest Group (SIG)
Find a Chapter
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Papers of the Week
Webinars and Podcasts
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Webinars & Podcasts
Curricula
Graduate Opportunities
Events

PATIENT & CAREGIVER

RELIEF News
Resources for Living with Pain
Global Alliance of Partners in Pain Advocacy (GAPPA)
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner

gy2022-1-3
I am a
IASP Logo
Home I AM A Search Login

Papers of the Week

Home / Publications / Pain Research Forum / Papers of the Week / Re-evaluating the Clinical Efficacy of Intrathecal Nalbuphine: Based on Minimal Clinically Important Difference and Statistical Threshold Correction.

< BACK TO ARCHIVE


2022 Feb 18


Pain Pract


http://www.ncbi.nlm.nih.gov/pubmed/35178877?dopt=Abstract

Re-evaluating the Clinical Efficacy of Intrathecal Nalbuphine: Based on Minimal Clinically Important Difference and Statistical Threshold Correction.

Authors

Re-evaluating the Clinical Efficacy of Intrathecal Nalbuphine: Based on Minimal Clinically Important Difference and Statistical Threshold Correction.
Dong J, Ren Y-F, Wei M-L, Ye X, Peng X-Y, Zhang L-F, Li F, Shi W
Pain Pract. 2022 Feb 18.
PMID: 35178877.
Read This Paper